The respiratory devices market size in Middle East Africa was worth USD 1.30 billion in 2022. It is further estimated to grow at a CAGR of 8.61% and will be worth USD 1.97 billion by 2027.
Respiratory devices aid patients suffering from respiratory problems which cannot attain sufficient oxygen levels to sustain life. The devices are used in chronic obstructive pulmonary disease (COPD), a deteriorating lung disease that mainly includes chronic bronchitis and emphysema.
The growth of the MEA respiratory devices market is primarily driven by the rising prevalence of respiratory diseases such as chronic obstructive pulmonary diseases (COPD), asthma, chronic bronchitis, pulmonary hypertension, pneumonia, and other respiratory diseases. These diseases are increasing due to constant environmental changes, tobacco, recurrent lower respiratory infections during childhood, air pollution, occupational chemicals, and dust driving the growth of the Middle East & African respiratory devices market. Also, technological advancements in respiratory devices for developing innovative and advanced devices are fuelling market growth. In addition, the increasing awareness among the people about various respiratory diseases with the increasing disposable income is propelling the growth of the MEA respiratory devices market.
On the other hand, the increase in investments from government and non-government in research and development activities for manufacturing new and advanced diagnosing devices and the rising incidences of preterm births in the region are uplifting the market growth. Furthermore, increasing urbanization, growing population, and healthcare expenditure contribute to the MEA respiratory devices market.
However, increase in the cost of the devices and treatment are majorly hampering the growth of the Middle East & African respiratory devices market. Also, strict government rules and regulations for introducing products in the market inhibit the market growth. In addition, lack of proper access to medical and health care devices for treatment procedures. Also, a lack of awareness among people about the risks associated with respiratory diseases is affecting the growth of the MEA respiratory devices market.
This research report on the Middle East and Africa respiratory devices market has been segmented and sub-segmented into the following categories:
The therapeutic devices segment is anticipated to hold a major share of the MEA respiratory devices market during the forecast period.
By End User:
The hospital segment was the largest in the market in 2021.
Based on region, The Middle East & Africa respiratory devices market is expected to account for a moderate share during the forecast period. The regional market growth is fuelled by the growing elderly population, the rising prevalence of respiratory diseases, and the improving healthcare sector. South Africa, UAE, and Saudi Arabia significantly contribute to the MEA regional market growth.
South Africa held the largest share of the MEA respiratory devices market and is likely to register significant growth during the forecast period. Respiratory diseases such as COPD and pulmonary tuberculosis are 30.2 percent, asthma and pneumonia are 51.9 percent, and are the most common diseases increasing in South Africa, mainly due to tobacco smoking and increasing pollution. In addition, asthma causes inflammation in the airways, resulting in coughing and developing chest tightness; it is also becoming more common in South Africa among youngsters.
Similarly, the UAE is likely to hold a considerable share in the Middle East & Africa respiratory devices market. Increased technological advancements drive the market growth, availability of well-equipped healthcare services and infrastructure, and an increase in the growing awareness among the people about treatment and precautions associated with respiratory diseases are projected to help the market growth.
On the other hand, Saudi Arabia is estimated to witness a promising share in the MEA respiratory devices market. The market growth is driven by increased investments and funding from government and non-government in research and development activities for manufacturing innovative devices. In addition, growing competition between players contributes to market growth.
KEY MARKET PARTICIPANTS:
Masimo Corporation, ResMed, Inc., Fisher and Paykel Healthcare Limited, Philips Healthcare, Covidien plc, and CareFusion Corporation are a few of the notable companies in the MEA respiratory devices market.
The MEA respiratory devices market is expected to grow at a CAGR of 8.61% from 2022 to 2027.
Saudi Arabia, the UAE, and South Africa are the leading countries in the MEA respiratory devices market
Saudi Arabia, the UAE, and South Africa are the leading countries in the MEA Respiratory Devices Market.
Lack of awareness about respiratory diseases and their management, the high cost of respiratory devices, and the shortage of trained healthcare professionals are some of the major challenges to the respiratory devices market in MEA.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com